Junctional adhesion molecule 4 (JAM4) is a cell adhesion molecule that interacts with a tight junction protein, membrane-associated guanylate kinase inverted 1 (MAGI-1). Our previous studies suggest that JAM4 is implicated in the regulation of paracellular permeability and the signalings of hepatocyte growth factor. In this study, we performed yeast two-hybrid screening to search for an unidentified JAM4-binding protein and obtained one isoform of Ligand-of-Numb protein X1 (LNX1), LNXp70, that is an interactor of Numb. Ligand-of-Numb protein X1 is expressed in kidney glomeruli and intestinal epithelial cells, where JAM4 is also detected. Immunoprecipitation from kidney lysates supports the in vivo interaction of proteins. Biochemical studies reveal that JAM4 directly binds the second PDZ domain of LNX1 through its carboxyl terminus. Junctional adhesion molecule 4, LNX1 and Numb form a tripartite complex in vitro and are partially colocalized in heterologous cells. Ligand-of-Numb protein X1 facilitates endocytosis of JAM4 and is involved in transforming growth factor b -induced redistribution of JAM4 in mammary epithelial cells. Experiments using dominant-negative constructs and RNA interference insure that Numb is necessary for the LNX1-mediated endocytosis of JAM4. All these findings indicate that LNX1 provides an endocytic scaffold for JAM4 that is implicated in the reorganization of cell junctions.
Tight junctions (TJs) serve as physiological intercellular barrier and intramembrane diffusion fence in epithelial and endothelial cells (Cereijido et al., 2000; Dejana et al., 2000; Tsukita et al., 2001; Schneeberger and Lynch, 2004) . Tight junctions comprise integral membrane proteins and membrane-associated proteins.
The latter proteins link membrane proteins to the cytoskeleton and cell signaling molecules. As integral membrane proteins, three classes of proteins have been identified. The first and second integral membrane proteins are occludin and claudin (Feldman et al., 2005; Van Itallie and Anderson, 2005) . Both of proteins have four transmembrane domains and two extracellular loops, and are involved directly in the formation of TJ strands. The members of immunoglobulin superfamily form the third group (Mandell and Parkos, 2005) . Junctional adhesion molecule (JAM) 4 was originally identified as a ligand for a TJ protein, membraneassociated guanylate kinase inverted 1 (MAGI-1) and belongs to this third group Tajima et al., 2003) . Junctional adhesion molecule 4 is detected at TJs in intestinal and mammary epithelial cells and the in vitro experiments show that JAM4 and MAGI-1 cooperate to regulate the paracellular permeability. We also found that JAM4 enhances the effect of hepatocyte growth factor (HGF) through the activation of a small GTP-binding protein, Rac (Mori et al., 2004) . Hepatocyte growth factor is a cytokine that regulates cell motility and migration and triggers the morphogenetic program in kidney and mammary epithelial cells (Stoker and Perryman, 1985; Nakamura et al., 1989) . It disrupts TJs and induces the formation of branching tubules. The conversion of polarized Madine Darby canine kidney (MDCK) cells to migratory fibroblast-like cells under the treatment of HGF is the first reported example of epithelial-to-mesenchymal transition (EMT). Epithelial-to-mesenchymal transition and its reverse process, mesenchymal-to-epithelial transition are fundamental to regulate morphogenesis during development (Thiery, 2003) . In cancer cells, EMT is considered as a potential mechanism for carcinoma progression (Larue and Bellacosa, 2005; Thompson and Newgreen, 2005) . Hepatocyte growth factor is relevant to the invasion and metastatic ability of cancer cells. Likewise transforming growth factor b (TGFb), which plays a pivotal role together with receptor tyrosine kinase signaling in EMT, enhances cell migration and contributes to cancer invasion and metastasis (Zavadil and Bo¨ttinger, 2005) . During EMT, the molecular structure of cell junctions is reorganized and differentiated junctions disappear. The previous observation that JAM4 is closely related the HGF-induced signaling in MDCK and HeLa cells prompted us to address the question how JAM4 is redistributed during the remodeling of TJs during EMT.
As a parallel experiment, we conducted yeast twohybrid screening to search for JAM4-binding proteins and identified one alternative splicing variant of Ligandof-Numb protein X1 (LNX1) called LNXp70 as an interactor for JAM4. Ligand-of-Numb protein X1 is a protein interacting with the cell fate determinant Numb (Dho et al., 1998) . One of splicing variants of LNX1, LNXp80 has a RING finger domain and targets Numb for ubiquitin-dependent degradation (Nie et al., 2002) . Numb is extensively studied in Drosophila (Uemura et al., 1989; Rhyu et al., 1994; Frise et al., 1996; Guo et al., 1996; Spana and Doe, 1996; Roegiers and Jan, 2004) . It contains a phosphotyrosine-binding (PTB) domain and associates with the plasma membrane through this domain. In mitotic neural precursor cells, Numb asymmetrically localizes and is segregated into one of daughter cells. In vertebrates, Numb is localized at the apical or basolateral cortex in mitotic neuroepithelial cells and its asymmetrical segregation influences the cell fates of daughter cells (Verdi et al., 1996; Zhong et al., 1996; Wakamatsu et al., 1999; Cayouette et al., 2001) . Numb directly binds to the intracellular domain of Notch and antagonizes Notch signaling (McGill and McGlade, 2003) . As Numb interacts with components of the endocytic machinery such as Eps15 and a-adaptin in Drosophila and mammals, it is proposed that Numb regulates Notch signaling through endocytosis of Notch (Salcini et al., 1997; Santolini et al., 2000; Berdnik et al., 2002) .
We first observed that JAM4 is redistributed from cell contacts to the cytoplasm in MDCK cells treated with various cytokines. We also confirmed endocytosis of JAM4 in mouse mammary epithelial NMuMG cells when treated with TGFb. Together with the finding that JAM4, LNXp70 and Numb form a tripartite complex in vitro, we speculated that LNXp70 provides JAM4 an endocytic scaffold and links it to Numb-mediated endocytic process. In this paper, we have reported the interaction of JAM4 and LNXp70 and discussed its potential role in endocytosis of JAM4 during TJ remodeling triggered by cytokines.
Results

JAM4 undergoes endocytosis during the remodeling of tight junctions
We previously reported that HGF induces robust branching in MDCK cells expressing FLAG-JAM4 (MDCK-JAM4 cells) and scattering in HeLa cells expressing FLAG-JAM4 (HeLa-JAM4 cells) at the lower dose than in control cells (Mori et al., 2004) . In the course of the study, we observed that HGF triggers the redistribution of FLAG-JAM4 in these cells (Figure 1) . In this study, we first tested the effect of other cytokines on the subcellular localization of JAM4. We treated MDCK-JAM4 cells with HGF, TGFb, activin and interferon g (IFNg). As previously reported, FLAG-JAM4 was detected mostly at cell contacts ( Figure 1a ) . After the treatment of all tested cytokines, signals of ZO-1 and FLAG-JAM4 came to be detected inside cells in addition to at cell contacts. We also compared FLAG-JAM4 clusters inside cells with those of early endosome marker protein, EEA1. The clusters formed under the treatment of TGFb well colocalized to EEA1 clusters (Figure 1b) . These findings support that JAM4 is redistributed during the reorganization of cell junctions. To further confirm the cytokine-dependent redistribution of JAM4, (MDCK-JAM4) were grown to the confluency and treated with various cytokines (50 ng/ml of hepatocyte growth factor (HGF), 50 ng/ml of transforming growth factor b (TGFb), 50 ng/ml of activin and 10 ng/ml of IFNg) for 36 h. Cells were immunostained with anti-FLAG and anti-ZO-1 antibodies. FLAG-JAM4 was colocalized with ZO-1 at cell contacts under no treatment. Tested cytokines induced the redistribution of FLAG-JAM4 and ZO-1. Bars, 20 mm. (b) MDCK-JAM4 cells were cultured in the medium containing 50 ng/ml of TGFb for 36 h and immunostained with anti-FLAG and anti-EEA1 antibodies. Demarcated areas are shown at bottom at higher magnification. Arrowheads show the colocalization of FLAG-JAM4 and EEA1. Bar, 10 mm.
we searched for cell lines expressing endogenous JAM4. As our antibody against JAM4 recognized only murine JAM4, we tested the expression of JAM4 in mouse mammary epithelial cells. The antibody gave signals in NMuMG and Eph-4 cells, which migrated as FLAG-JAM4 expressed in MDCK cells in SDS-PAGE, but not in C57MG cells (Figure 2a , left panel). The adsorption experiment using the JAM4 antigen confirmed that the signals in NMuMG and Eph-4 cells virtually reflect endogenous JAM4 (data not shown). As EMT is well studied in NMuMG cells, we examined the effect of TGFb on the subcellular localization of JAM4 in these cells. Junctional adhesion molecule 4 was localized at cell contacts in confluent NMuMG cells (Figure 2b, upper panel, an arrow) . As the cells have flat morphology, we could not clearly show the colocalization with ZO-1 at TJs in x-z section, but both proteins were well overlapped in x-y section. NMuMG cells treated with TGFb showed an elongated spindle morphology characteristic of EMT (Figure 2b , lower panel). We also confirmed the reduced expression of E-cadherin under this condition (data not shown). Junctional adhesion molecule 4 was detected inside cells and partially colocalized with EEA1 ( Figure 2b , lower panel, arrowheads).
Identification of LNX1 as a novel JAM4-interacting protein In search for a novel interacting protein with JAM4, we performed yeast two-hybrid screening using human kidney cDNA library with the cytoplasmic region of JAM4 as a bait and obtained 10 positive clones. Among them, two clones, pPrey 18001 and pPrey 18008 encoded the C-terminal 607 amino acids of human LNX protein (Gene accession number, AAH22983) and the C-terminal 374 amino acids of human PDZ domain containing Ring finger 1 protein (Gene accession number NP_699202), respectively. These proteins correspond to mouse LNX1 (also designated as LNXp70) (Gene accession number NP_034857.2) and LNX2 (Gene accession number Q91XL2). Ligand-ofNumb protein X1 is a Numb-binding molecule and LNX2 is an isoform of LNX1. Ligand-of-Numb protein X1 has two splicing variants. LNXp70 has four PDZ domains, whereas LNXp80 has an N-terminal RING LNX1 is an endocytic scaffold for JAM4 A Kansaku et al finger domain followed by four PDZ domains. We expressed the C-terminal half region of LNXp70 covering four PDZ domains as maltose-binding protein (MBP)-fusion protein and used it as an antigen. We also prepared Myc-tagged construct using mouse NP_034857.2 to express it in COS-7 cells. The antibody recognized a protein in various tissues (Figure 3a) . The protein had the same size as that of Myc-LNX1. Although the protein is described as LNXp70 in GenBank, the gene product migrated as a protein with 
LNX1 is an endocytic scaffold for JAM4
A Kansaku et al reacted with LNX2 (data not shown). In this study, we focused on LNXp70 (described as LNX1 in this paper). To confirm the interaction between LNX1 and JAM4, we performed the co-immunoprecipitation experiment. Endogenous LNX1 was immunoprecipitated from kidney lysates and we detected JAM4 in the immunoprecipitate, suggesting that LNX1 and JAM4 indeed interact with each other in vivo ( Figure 3b ). Next, we examined the subcellular localization of LNX1 and compared it with that of JAM4. In the immunofluorescence of rat kidney, anti-LNX antibody detected signals in the glomeruli (Figure 3c ). Ligand-of-Numb protein X1 was rather diffuse in podocytes, whereas ZO-1 was restricted to the slit diaphragm. Ligand-ofNumb protein X1 in intestinal epithelial cells was detected on apical membranes as we previously reported for JAM4 ( Figure 3d ) . All these findings support that LNX1 was coexpressed in the same cells as JAM4. To more closely compare the localization of LNX1 with that of JAM4, we made use of MDCK-JAM4 cells. When the cells were stained with rabbit anti-LNX, mouse anti-FLAG and rat anti-ZO-1 antibodies, the signal recognized by anti-LNX antibody was colocalized with FLAG-JAM4 and ZO-1 (Figure 3e ).
JAM4 interacts with the second PDZ domain of LNX1 by its PDZ-binding motif
To analyse the interaction between LNX1 and JAM4, we used heterologous cells. We coexpressed GFP-LNX1 with FLAG-JAM4 in COS-7 cells and immunoprecipitated FLAG-JAM4 with anti-FLAG antibody from the lysates. GFP-LNX1 was co-precipitated with FLAG-JAM4 ( Figure 4a ). As JAM4 has a PDZ-binding motif at its C-terminus, we speculated that JAM4 interacts with PDZ domain(s) of LNX1 by this motif. To test this possibility, we coexpressed GFP-LNX1 and FLAG-JAM4-DC lacking the C-terminal nine residues and immunoprecipitated FLAG-JAM4-DC with anti-FLAG antibody from the lysates. GFP-LNX1 was not coprecipitated with FLAG-JAM4-DC, indicating that the C-terminus of JAM4 is involved in the interaction with LNX1. Next, to map the JAM4-interacting domain of LNX1, we prepared various constructs of LNX1 ( Figure 5 ). We first confirmed that GST-fusion protein containing the cytoplasmic region of JAM4 (GST-JAM4-C) interacted with GFP-LNX1-C, but not with GFP-LNX1-N (Figure 4b ). We further tested various Myc-tagged LNX1 constructs transfected in COS-7 cells (Figure 4c ). GST-JAM4-C captured Myc-LNX1-2 and Myc-LNX1-3 but not Myc-LNX1-4, suggesting that the second PDZ domain of LNX1 is involved in the interaction with JAM4. To directly confirm that the second PDZ domain binds to JAM4, we prepared MBPfusion proteins containing each PDZ domain of LNX1 (MBP-LNX1-PDZ1, MBP-LNX1-PDZ2, MBP-LNX1-PDZ3 and MBP-LNX1-PDZ4) and evaluated them for the binding to GST-JAM4-C. GST-JAM4-C trapped MBP-LNX1-PDZ2, but not MBP-LNX1-PDZ1, MBP-LNX1-PDZ3 or MBP-LNX1-PDZ4 (Figure 4d ). Control GST or GST-JAM4-DC did not trap any of the MBP-fusion proteins. In conclusion, the C-terminus of JAM4 interacts with the second PDZ domain of LNX1. Furthermore, the data indicate that the interaction between JAM4 and LNX1 is direct and does not involve other proteins.
LNX1 facilitates endocytosis of JAM4 LNX1 was originally identified as a Numb-binding protein and Numb is known to be involved in endocytosis (Dho et al., 1998; Santolini et al., 2000) . This led us to study how LNX1 influences endocytosis of JAM4.
For this purpose, we used HeLa-JAM4 cells. First, we expressed control GFP or GFP-LNX1 in HeLa-JAM4 cells and incubated cells with anti-FLAG antibody alive. Subsequently, we induced endocytosis by temperature shift, stripped the antibody from cell surface FLAG-JAM4 by acid treatment and fixed cells to visualize the internalized antibody. Even after endocytosis was induced, FLAG-JAM4 was still detected at cell contacts in both cells expressing control GFP and GFP-LNX1 (Figure 6a ). However, some clusters appeared inside cells after the temperature shift. Although the redistribution of FLAG-JAM4 from cell contacts was observed in both of cells expressing GFP and GFP-LNX1, the latter cells showed more clusters of FLAG-JAM4 outside cell contacts (Figure 6a , an arrow in the lower panel). FLAG-JAM4 was partially colocalized with GFP-LNX1 and EEA1 (Figure 6a , arrowheads at the bottom in the lower panel). The biochemical surface biotinylation also supported that LNX1 facilitates endocytosis of JAM4 (Figure 6b ).
LNX1 forms a tripartite complex with JAM4 and Numb
The interaction between Numb and LNX1 is mediated by the Numb PTB-binding NPAY motif and the first PDZ domain of LNX1 (Dho et al., 1998; Nie et al., 2004) . As JAM4 binds to the second PDZ domain of LNX1, we reasoned that JAM4 and Numb may bind to LNX1 simultaneously. To test this idea, we performed a pull-down assay using GST-JAM4-C for Myc-Numb. GST-JAM4-C did not trap Myc-Numb (Figure 7 , left panel). COS-7 cells have endogenous LNX1 and the immunoblotting with anti-LNX1 antibody showed a weak signal at the longer exposure, although the amount appeared very small (data not shown). Subsequently, we overexpressed GFP-LNX1. Then, Myc-Numb was captured by GST-JAM4-C together with GFP-LNX1 ( Figure 7 , right panel). This result implies that LNX1 links JAM4 to Numb and that these proteins form a tripartite complex. The complex composed of JAM4, LNX1 and Numb suggests the possibility that Numb is involved in the LNX1-mediated endocytosis of FLAG-JAM4. We overexpressed Numb in HeLa-JAM4 cells and assessed whether Numb affects the LNX1-mediated endocytosis of FLAG-JAM4. The clone that we obtained from IMAGE consortium is a long isoform of mouse Numb with the inserts both in the PTB domain and the proline-rich carboxyl terminal region (Verdi et al, 1996; Dho et al., 1999) . The accumulation of FLAG-JAM4 appeared to be more detectable in a cell coexpressing GFP-LNX1 and HA-Numb than in a cell expressing GFP-LNX1 alone ( Figure 8a , the second panel, an arrow and an arrowhead). As the in vitro interaction described in Figure 7 suggests, HA-Numb was partially colocalized with GFP-LNX1 and FLAG-JAM4. In contrast, the C-terminal deleted HA-Numb-2 and the N-terminal deleted HA-Numb-3 cancelled the effect of LNX1 (Figures 5 and 8a , the third and fourth panels, arrowheads). To further confirm the involvement of Numb, we used RNA interference to reduce endogenous Numb. The dsRNA specific for human Figure 5 Schematic drawing of Ligand-of-Numb protein X1 (LNX1) and Numb constructs used in this study. The numbers indicate the first and last amino-acid residues that each construct contains. NPAY is the sequence involved in the interaction with Numb. White ovals, rectangles and circles indicate GFP-tag, Myctag and HA-tag, respectively. Gray boxes show PDZ domains. Phosphotyrosine-binding domain is depicted as a black box. DPF and NPF show the sequences binding a-adaptin and Eps15.
Numb suppressed endogenous Numb in HeLa cells (Figure 8b, left) . Numb antibodies detected two bands in HeLa cells and both of them were suppressed. We assumed that these bands reflect splicing variants of Numb. GFP-LNX1 did not enhance endocytosis of FLAG-JAM4 in the cells where the expression of Numb was suppressed (Figure 8b, right) . We also performed the biochemical surface biotinylation. The coexpression of Myc-Numb augmented the effect of LNX1, while knockdown of Numb blocked it (Figure 8c ). We next tested the truncated LNX1 ( Figure 5 ). GFP-LNX1-2 interacts with JAM4 but not with Numb. Intracellular clusters of FLAG-JAM4 decreased in cells expressing GFP-LNX1-2 (Figure 9 ). These data suggest that the complex formation of JAM4, LNX1 and Numb is required to facilitate the endocytosis of JAM4. 
LNX1 is involved in the redistribution of JAM4 in NMuMG cells treated with TGFb
We next addressed a question whether LNX1 is indeed involved in endocytosis of endogenous JAM4. Ligandof-Numb protein X1 is expressed in NMuMG cells (Figure 2a, right panel) . Therefore, we induced EMT by TGFb in these cells to test whether LNX1 is necessary for the redistribution of JAM4. When GFP-LNX1 was expressed in NMuMG cells, it was partially accumulated at cell contacts, although it was detected in the cytosol, too (Figure 10a, upper panel) . In contrast, control GFP was not concentrated at cell contacts (data not shown). After TGFb-treatment, GFP-LNX1 formed clusters inside cells (Figure 10a , the third panel, arrowheads). These clusters were partially overlapped with clusters of JAM4. However, when GFP-LNX1-2 was expressed in NMuMG cells, JAM4 remained at cell contacts after TGFb-treatment ( Figure 10a , the fourth panel, an arrow). We also performed a knockdown experiment. Although we first tested several short interfering RNA duplexes designed for mouse LNX1, we could not suppress the expression of LNX1 in NMuMG cells. Therefore, we utilized microRNA (miRNA) for RNA interference. The designed miRNA efficiently suppressed the expression of LNX1 (Figure  10b, left) . In cells transfected with pEmGFP miRNA-LNX1, where GFP was expressed as a tracer, JAM4 remained at cell contacts after the treatment with TGFb (Figure 10b , an arrow). The data support that LNX1 is involved in the TGFb-induced redistribution of JAM4 in NMuMG cells.
Discussion
Hepatocyte growth factor is the first identified cytokine involved in EMT and plays a role in tubulogenesis and branching (Stoker and Perryman, 1985; Nakamura et al., 1989; Zhang and Woude, 2003) . Hepatocyte growth factor regulates cell motility and triggers the remodeling of cell junctions (Pollack et al., 2004) . Under the treatment of HGF, the surface expression of cell adhesion proteins alters through shedding and endocytosis (Kamei et al., 1999; Tanaka et al., 2002; Heiz et al., 2004) . Transforming growth factor b , which is also a well-established inducer of EMT, downregulates the expression of E-cadherin and increases the expression of N-cadherin (Miettinen et al., 1994; Zavadil and Bo¨ttinger, 2005) . These findings imply that subcellular localization and expression of cell adhesion molecules need to be modified during the remodeling of cell junctions. In this study, we examined whether and how JAM4 is redistributed under the effect of these cytokines. We found that LNX1, which we identified as a novel JAM4-interacting protein, is involved in this process.
LNX1 is a ligand for Numb that is an endocytic protein and is involved in Notch signaling (Dho et al. 1998; Roegiers and Jan, 2004) . Ligand-of-Numb protein X1 has two alternative splicing variants, p70 and p80. The latter protein has a RING finger domain and targets Numb for ubiquitin-dependent degradation, whereas the former protein does not harbor this domain. Although the original paper reported the absence of the message of LNXp70 in kidney, the clone that we obtained in the screening from human kidney cDNA library encoded LNXp70 but not LNXp80, and the kidney protein recognized by our antibody has the same size as LNXp70 (Dho et al., 1998) . Therefore, we examined the interaction between JAM4 and LNXp70 in this study. Ligand-of-Numb protein X1 was co-immunoprecipitated with JAM4 from kidney lysates. Ligand-of-Numb protein X1 was detected in the glomerular fraction in the immunoblotting and in podocytes and intestinal epithelial cells in the immunofluorescence. We also confirmed the colocalization of endogenous LNX1 with FLAG-JAM4 in MDCK cells. These findings support that LNX1 and JAM4 indeed interact with each other in vivo. Biochemical studies using heterologous cells and recombinant proteins indicate that the C-terminus of JAM4 directly binds to the second PDZ domain of LNX1 in vitro. A recent study has revealed that CAR, an immunoglobulin-like cell adhesion molecule, interacts with LNX1 (Sollerbrant et al., 2003) . In this case, a deletion of the last three residues of CAR disrupts the interaction but a truncation of the thirteen amino acids partially recovers the interaction. This complicated result implies that CAR has a LNX1-interacting sequence besides the PDZ-binding motif and the second interacting region is masked in the truncated protein lacking the C-terminal three amino acids. As we simply tested a truncation of the C-terminal nine amino acids, we cannot exclude the possibility that JAM4 has the second LNX1-binding site. Even so our data indicate that the C-terminus of JAM4 is important for the interaction. It is also to note that the interaction of CAR with LNX2 depends on the C-terminal nine amino acids of CAR (Mirza et al., Figure 7 Ligand-of-Numb protein X1 (LNX1) links JAM4 to Numb. Myc-Numb was expressed in COS-7 cells alone or together with pBudCGFP-LNX1. Lysates were incubated with control GST or GST-junctional adhesion molecule 4 (JAM4)-C proteins immobilized on glutathione Sepharose beads. After the beads were washed, the precipitates were analysed by SDS-PAGE and immunoblotted with anti-Myc antibody. Myc-Numb was trapped by GST-JAM4-C when GFP-LNX1 was coexpressed (right panel), whereas it did not directly interact with GST-JAM4-C (left panel). Protein standards are indicated on left in kilodaltons (kDa). 2005). Although we focused on LNXp70 in this study, LNXp80 is likely to interact with JAM4, because LNXp80 has the JAM4-binding PDZ domain. Moreover, we also obtained LNX2 from the original yeast two-hybrid screening, suggesting that LNX2 is likewise a binding partner for JAM4. The molecular structure of LNX2 is similar to LNXp80 and has a RING finger domain (Rice et al., 2001 ). In the case that JAM4 is anchored to LNXp80 or LNX2, JAM4 may be degraded after endocytosis.
We have also demonstrated that LNX1-mediated endocytosis of JAM4 depends on Numb. Numb has the C-terminal Eps15 homology domain and interacts with Eps15 and a-adaptin (Salcini et al., 1997; Santolini et al., 2000; Berdnik et al., 2002) . Numb furthermore binds EHD/Rme-1 proteins that play a role in recycling endocytosed receptors (Smith et al., 2004) . These endocytic components bind to the C-terminal region of Numb, while LNX1 binds to the PTB domain. Numb and JAM4 bind to different sequences of LNX1. As expected, Numb forms a complex with JAM4 via LNX1. Experiments using RNA interference and truncated mutants of Numb support that the LNX1-mediated endocytosis of JAM4 depends on Numb.
Notch signaling is important in the development of tissues expressing JAM4 including mammary gland, intestine and kidney. Notch is also involved in oncogenesis in these tissues. Int-3, one of the activated genes in mouse mammary tumor virus model, encodes a truncated Notch4 (Nusse and Varmus, 1982; Gallahan and Callahan, 1997; Politi et al., 2004) . Notch1 is also involved in mammary tumors (Dievart et al., 1999) . Mutant mice deficient for HES-1 that is a Notch target gene and for MATH-1 that is a target gene of HES-1-mediated repression, show abnormal development in intestine (Jensen et al., 2000; Yang et al., 2001; Sancho et al., 2004) . A recent study has directly demonstrated the control by Notch of progenitor cells in intestine (Fre et al., 2005) . Notch1, Notch2 and Notch ligands are present in the developing kidney and glomerulus (Weinmaster et al., 1991; Beckers et al., 1999) . Notch2 mutant mice have glomerular defects (McCright et al., 2001) . It is an important issue of future studies to examine whether JAM4 influences Notch signaling through LNX1 and Numb or whether Notch signaling triggers endocytosis and degradation of JAM4. As discussed above, CAR binds the PDZ domain of LNX1. Although no experimental data were presented, CAR is likely to form a complex with LNX1 and Numb. Interestingly, CAR is a basolateral protein in polarized epithelial cells, whereas JAM4 is an apical protein.
Moreover, tissue distribution of CAR is different from that of JAM4 (Coyne and Bergelson, 2005) . As CAR is proposed to be essential for development of heart and brain, CAR may play a similar, if not the same, role in Notch signaling. This issue also needs to be studied in the future.
Materials and methods
Yeast two-hybrid screening PCR was performed by using primers (5 0 -aggcctaatgagtgaggt aactc-3 0 and 5 0 -gacgtcgttcaggtggcacttttc-3 0 ) on pGBKT7 (BD Biosciences Clontech, Palo Alto, CA, USA) and the PCR fragment was digested by StuI/AatII and ligated into PvuII/ AatII sites of pBTM116 to generate pBTM116 KM vector. pBTM116 KM JAM4-C was prepared by using EcoRI/Sall sites of pBTM116 KM and encodes the cytoplasmic region of JAM4 (amino acids 262-370). Yeast two-hybrid screening was performed using a human kidney cDNA library (BD Biosciences Clontech) and yeast strain L40. Histidine selection plates contained 8 mM 3-amino-1,2,4-triazole and 360 mg/l of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside. After 6 days of incubation, blue colonies were picked up for further analysis.
Construction of vectors
Mouse cDNAs of LNX1 and LNX2 were obtained by PCR using primers (5 0 -gaattcaaggcgctgctgcttctggtc-3 0 and 5 0 -gtcgactat aaaaaagtaccaggccaag-3 0 , and 5 0 -acgcgtggaacaaccagtgacgaga-3 0 and 5 0 -gcggccgctatacgaggctgcctggc-3 0 ) on mouse kidney and brain cDNA (BioChain Institute, Hayward, CA, USA), respectively. pGex4T-1 JAM4-C, pGex4T-1 JAM4-DC, pLN FLAG-JAM4 and pLN FLAG-JAM4 DC were described previously . pCIneo Myc vector was described previously (Hirao et al., 1998) . pCIneoHA vector was generated by ligating a linker (5 0 -ctaggcccccaacatgtacccata cgacgtcccagactacgctctcgagg-3 0 and 5 0 -aattcctcgagagcgtagtctg ggacgtcgtatgggtacatgttgggggc-3 0 ) into NheI/EcoRI sites of pCIneo. pBudCE4.1 vector (Invitrogen, Carlsbad, CA, USA) was digested with NheI, filled in by Klenow enzyme, and religated. The resulting vector was used to generate pBudCE4.2 by ligating the first linker (5 0 -agcttgctagcgaattcgga tcctgcagctcgagatatc-3 0 and 5 0 -aattgatatctcgagctgcaggatccgaattc gctagca-3 0 ) into HindIII/EcoRI site and the second linker (5 0 -ggcctctagaagatctacgcgtggtaccgtcgacgcggc-3 0 and 5 0 -cgcggccgc gtcgacggtaccacgcgtagatcttctaga-3 0 ) into NotI/MluI site. PCR was performed on pLGFPC vector (BD Biosciences Clontech) with primers (5 0 -gcactagttttggcaccaaaatcaacg-3 0 and 5 0 -cgcatgcacgcgt gacgtctctagacttgtacagctcgtcca-3 0 ), and the PCR product was digested by SpeI/XbaI and ligated into NheI site of pBudCE4.2 to obtain pBudCGFP vector. The following constructs were made using EcoRI/XhoI sites of pBudCGFP and EcoRI/Sall sites of pClneoMyc and pMalC2 (New England Biolabs) vectors and encoded the following amino acids of mouse LNX1 (Gene accession number, NP_034857); pBudCGFP LNX1, pClneoMyc LNX1 and pMal LNX1, 2-628; pBudCGFP-LNX1-N, Figure 9 GFP-Ligand-of-Numb protein X1 (LNX1)-2 blocked the endocytosis of FLAG-junctional adhesion molecule 4 (JAM4) in HeLa-JAM4 cells. HeLa-JAM4 cells were transfected with pBudCGFP-LNX1-2. Cells were incubated with rabbit polyclonal anti-FLAG antibody alive at 41C and shifted to 371C. After acid stripping, cells were fixed, permeabilized and subsequently with rhodamine-conjugated anti-rabbit second antibody. Arrow indicates a cell expressing GFP-LNX1-2, in which intracellular FLAG-JAM4 clusters were hardly detected. In contrast, FLAG-JAM4 formed clusters in a cell without GFP-LNX1-2 indicated by arrowhead. Bar, 20 mm.
2-186; pBudCGFP LNX1-C, pClneoMyc LNX1-2 and pMal . pBudCGFP-LNX1-FLAG-JAM4 and pBudCGFP-LNX1-FLAG-JAM4-DC were generated by ligating BgIII/Sall fragments from pLN FLAG-JAM4 and pLN FLAG-JAM4-3 into BgIII/Sall sites of pBudCGFP LNX1 . pCIneo Myc LNX2 contains the amino acids 2-687 of mouse LNX2 (Gene accession number, Q91XL2). Mouse Numb cDNA (Gene accession number, BC033459) was purchased from Open Biosystems and used to generate Numb constructs containing the following amino acids; pClneoMyc and pClneoHA Numb, 8-853; pClneoHA Numb-2, 8-790 and pClneoHA Numb-3, 348-853. pBudCGFP LNX1-Myc-Numb encodes GFP-LNX1 under cytomegalovirus promoter and Myc-Numb under elongation factor-1a promoter. Oligonucleotides, tgctgttacatgg aagctgtcatcccgttttggccactgactgacgggatgaccttccatgaa and cctgt tacatggaaggtcatcccgtcagtcagtggccaaaacgggatgacagcttccatgtaac were annealed and ligated into pcDNA6.2-GW/EmGFPmiRNA vector (Invitrogen Corp.) to generate pEmGFP miRNA-LNX1. Irrelevant oligonucleotides, tgctgataggaatctgg gtcctgtccgttttggccactgactgacggacaggacagattcctat and cctgatagg aatctgtcctgtccgtcagtcagtggccaaaacggacaggacccagattcctatc, were used to generate a negative control vector. The constructs used in this study are summarized ( Figure 5 ).
Antibodies
Anti-JAM4 and anti-MAGI-1 antibodies were described previously . MBP-fusion protein was purified using amylose resin (New England Biolabs, Beverly, MA, USA) from lysates of Escherichia coli transformed by pMal LNX1-2 and used as an antigen to obtain rabbit polyclonal anti-LNX antibody. Affinity purified antibodies were used for the immunohistochemical analysis. The following antibodies were purchased from the commercial sources: mouse monoclonal anti-ZO-1 (Zymed Laboratories, San Francisco, CA, USA); rat polyclonal anti-ZO-1 (Chemicon, Temecula, CA, USA); mouse monoclonal anti-Myc-tag 9E10 (American Type Culture Collection, Rockville, MD, USA); mouse monoclonal anti-HA (Roche Diagnostics, Mannheim, Germany); mouse monoclonal anti-EEA1 and mouse monoclonal anti-b-catenin (Transduction Laboratories, San Diego, CA, USA); mouse monoclonal anti-FLAG M2 and mouse monoclonal anti-MBP, rabbit polyclonal anti-FLAG and rabbit polyclonal anti-actin (Sigma-Aldrich, St Louis, MO, USA); rabbit polyclonal anti-Numb (Upstate Biotechnology) and rhodamine-conjugated, fluorescein isothiocyanate (FITC)-conjugated, and Cy5-conjugated second antibodies for dual labeling (Chemicon International).
Cell culture and transfection COS-7 cells were grown in cultures in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/ml of penicillin and 100 mg/ml of streptomycin under 5% CO 2 at 371C. For NMuMG cells, 10 mg/ml of insulin (Sigma-Aldrich) was added. Transfection was performed using DEAE-dextran method for COS-7, Effectene transfection reagent (Qiagen) for MDCK cells and Lipofectamine 2000 (Invitrogen Corp.) for HeLa and NMuMG cells. Stable transformants of MDCK and HeLa cells expressing FLAG-JAM4 were prepared and cultured as described previously Mori et al., 2004) . For RNA interference experiment to knockdown Numb, a 21-nucleotide oligomer composed of 5 0 -ccggaaauguagcuuccctt-3 0 and 5 0 -ggga agcuacauuuuccggtg-3 0 (Ambion Silencer predesigned siRNA #16708) was transfected using Lipofectamine 2000 (Invitrogen Corp.). As a control, Silencer negative control #1 siRNA (Ambion) was used.
Immunofluorescence microscopy Madine Darby canine kidney cells were fixed with 3.7% (w/v) formaldehyde in phosphate-buffered saline (PBS) at room temperature for 15 min and blocked with 50 mM glycine in PBS for 30 min. NMuMG cells were fixed with ice-cold methanol. The samples were incubated with 0.2% (w/v) Triton X-100 in PBS for 15 min and subsequently with 1% (w/v) bovine serum albumin (BSA) in PBS at room temperature for 30 min. The samples were incubated with various first antibodies and visualized with appropriate second antibodies. Images were obtained by Zeiss LSM 510 confocal microscope and Olympus IX71 CCD microscope. HeLa-JAM4 cells were incubated with anti-FLAG antibody alive in the medium for 1 h at 41C to stop endocytosis. After washed with cold PBS, cells were incubated for 15 min at 371C to allow the internalization of surface proteins and treated with the acid stripping solution containing 0.2 M acetic acid and 0.5 M NaCl for 2 min at 41C. Subsequently, cells were blocked, permeabilized, immunostained using other antibodies and visualized with second antibodies as described above for MDCK and NMuMG cells.
Immunohistochemistry
All procedures related to the care and treatment of animals were in accordance with the institutional guideline. Wistar rats (4 weeks old) were deeply anesthetized with pentobarbital sodium (60 mg/kg of body weight, intraperitoneally administered) and perfused with 2% paraformaldehyde fixative buffered with 0.1 M phosphate buffer (pH 7.4) for kidney and 4% paraformaldehyde fixative with PBS for intestine. These samples were immersed in the same fixative for about 30 min for kidney and overnight for intestine. After washing with PBS, the tissue was immersed successively in PBS solution containing 10, 15 and 20% sucrose for kidney, while 10, 20 and 30% sucrose were used for intestine. After the tissue was embedded in OCT compound and frozen, cryosections (thickness 5-10 mm) were cut using a Jung Frigocut 2800E (Leica) and then mounted on silane-coated glass slides for kidney. For intestine, Leica 818 (Leica) and APS-coated glass slides were used. The cryosections were rinsed with PBS and blocked in blocking solution (0.1% BSA in PBS) for kidney and (5% goat serum and 0.2% TritonX-100 in PBS) for intestine. The sections were incubated with various first antibodies and visualized with rhodamine-or FITC-conjugated second antibodies. Fluorescence specimens were viewed with a confocal laser scanning microscope LSM510 (Carl Zeiss) for kidney and Olympus IX70 for intestine.
Immunoprecipitation
Two adult rat kidneys were homogenized in 4 ml of the hypotonic buffer (25 mM Tris-HCl (pH 8.8), 10 mg/l leupeptin, 1 mM 4-amidinophenylmethanesulfonyl fluoride and 10 mg/l aprotinin) and centrifuged at 100 000g for 15 min at 41C. The pellet was rinsed twice with the same buffer and resuspended in 4 ml of the hypotonic buffer. About 0.5 ml of 250 mM Tris-HCl (pH 8.8) containing 10% (w/v) sodium deoxycholate was added. After 30-min incubation at 361C, 0.5 ml of 50 mM TrisHCl (pH 8.8) containing 1% (w/v) Triton X-100 was added. The mixture was dialysed against 2 l of 50 mM Tris-HCl (pH 7.4) containing 0.1% (w/v) Triton X-100 with one exchange. After the centrifugation at 37 000g for 30 min at 41C, the supernatant was incubated with either 1 ml of anti-LNX or anti-JAM4 antiserum prefixed on 10 ml of protein G Sepharose four fast-flow beads (Amersham Biosciences) for 6 h at 41C. The immunoprecipitates were immunoblotted with either anti-JAM4 or anti-LNX serum. For in vitro binding assays, COS-7 cells were transfected by DEAE-dextran with various expression vectors. Cells from one 10-cm diameter plates were homogenized in 400 ml of 25 mM Tris-HCl (pH 8.0) containing 100 mM NaCl, 1% (w/v) Triton X-100 and 1% (w/v) sodium deoxycholic acid and centrifuged at 100 000g for 15 min at 41C. The supernatant was incubated with 1 ml of anti-JAM4 serum fixed on 10 ml of protein G Sepharose four fast-flow beads. After the beads were washed, the precipitates were analysed by SDS-PAGE and immunoblotted with the indicated antibodies.
GST pull-down assay Lysates of COS-7 cells transfected with various LNX1 constructs were prepared as described for the immunoprecipitation experiments. These lysates or 250 pmol of various purified recombinant MBP-fused LNX1 proteins were incubated with either 250 pmol of GST or various GST-fused proteins fixed on 10 ml of glutathione Sepharose beads in 400 ml of 25 mM Tris-HCl (pH 8.0) containing 100 mM NaCl and 1% (w/v) Triton X-100. After the beads were washed, the proteins on the beads were immunoblotted with appropriate antibodies. To test a tripartite complex of LNX1, Numb and JAM4, lysates of COS-7 cells expressing Myc-Numb alone or coexpressing Myc-Numb and GFP-LNX1 were incubated with either control GST or GST-JAM4-C proteins.
Surface biotinylation and trafficking assays HeLa-JAM4 cells were plated at 2 Â 10 6 cells per each 10-cm culture dish in the complete medium and transfected with appropriate vectors using Lipofectamine 2000 (Invitrogen Corp.). After 6 h, cells from each 10-cm dish were replated to six 6-cm culture dishes. 24 h after the transfection, cells were washed twice with ice-cold PBS (pH 8.0), incubated with 0.5 mg/ml of sulfo-NHS-SS-biotin (Pierce) in PBS for 30 min at 41C to biotinylate surface proteins and washed twice with PBS. Two dishes of six were kept at 41C. These samples were washed with ice-cold PBS and then one of them was kept with no treatment, while the other was incubated for 15 min in 1.5 ml of the cleavage solution (50 mM Tris-HCl (pH 8.7) containing 50 mM sodium 2-mercaptoethanesulfonate (MESNA), 100 mM NaCl and 2.5 mM CaCl 2 . The first one represents the biotinylation efficiency. The second one verifies that MESNA removes biotin from surface proteins. For the remaining dishes, the medium was replaced by prewarmed PBS and incubated at 371C. After various incubation time, each dish was washed with ice-cold PBS and treated with the cleavage solution. Cells from each dish were lysed in 300 ml of the lysis buffer (25 mM Tris-HCl (pH 8.0) containing 100 mM NaCl, 1% (w/v) Triton X-100, 1% (w/v) deoxycholate, 10 mg/l leupeptin, 1 mM 4-amidinophenylmethanesulfonyl fluoride and 10 mg/l aprotinin). The lysates were centrifuged at 100 000g for 15 min at 41C and incubated with 0.5 ml of anti-FLAG antibody immobilized on protein G Sepharose beads. The precipitated proteins were immunoblotted using ABC kit (Vector Laboratories) and ECL reagent (Amersham Biosciences) to evaluate biotinylation.
